EP0929694A4
(de)
*
|
1996-03-15 |
2002-05-02 |
Penn State Res Found |
Nachweis von extrazellulärer tumor-assoziierter nukleinsäuren im blutplasma oder -serum mittels eines nukleinsäure-amplifizierungsverfahren
|
US6511805B1
(en)
*
|
1996-03-15 |
2003-01-28 |
The Penn State Research Foundation |
Methods for detecting papillomavirus DNA in blood plasma and serum
|
US8048629B2
(en)
|
1996-03-15 |
2011-11-01 |
The Penn State Research Foundation |
Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
|
US7785842B2
(en)
|
1996-03-26 |
2010-08-31 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US6794135B1
(en)
*
|
1996-03-26 |
2004-09-21 |
Oncomedx, Inc. |
Method for detection of 5T4 RNA in plasma or serum
|
US6607898B1
(en)
*
|
1996-03-26 |
2003-08-19 |
Oncomedx, Inc. |
Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
|
EP0938320B2
(de)
*
|
1996-03-26 |
2014-06-18 |
Michael S. Kopreski |
Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
|
US6759217B2
(en)
*
|
1996-03-26 |
2004-07-06 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US8043835B1
(en)
|
1996-03-26 |
2011-10-25 |
Oncomedx, Inc. |
Methods for detecting and monitoring cancer using extracellular RNA
|
EP0960210A4
(de)
*
|
1996-10-04 |
2004-06-09 |
Chronix Biomedical |
Diagnostische nukleinsäure-detektion
|
US8440396B2
(en)
|
1997-03-14 |
2013-05-14 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US20070009934A1
(en)
*
|
1997-03-14 |
2007-01-11 |
Kopreski Michael S |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
WO1998046788A2
(en)
*
|
1997-04-11 |
1998-10-22 |
Micromet Gesellschaft Für Biomedizinische Forschung Mbh |
Primers and methods for the detection of disseminated tumor cells
|
US7229772B1
(en)
|
1998-03-18 |
2007-06-12 |
Roche Diagnostics Gmbh |
Detection of apoptotic products
|
JP3517642B2
(ja)
*
|
1998-03-18 |
2004-04-12 |
ロシュ ダイアグノスティックス ゲーエムベーハー |
アポトーシス産物の検出
|
DE19836559A1
(de)
*
|
1998-08-12 |
2000-03-23 |
Antigen Gmbh |
Gefäß zur Entnahme von Blut
|
US8163524B2
(en)
*
|
1998-09-22 |
2012-04-24 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US7767422B2
(en)
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
US20090233276A1
(en)
*
|
1998-09-22 |
2009-09-17 |
Oncomedx, Inc. |
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
|
US20060204989A1
(en)
*
|
1998-09-22 |
2006-09-14 |
Kopreski Michael S |
Comparative analysis of extracellular RNA species
|
EP1158055A1
(de)
*
|
2000-05-26 |
2001-11-28 |
Xu Qi University of Teaxs Laboratoire de Leucémie Chen |
Verfahren zur Diagnose von Krebs
|
ATE498020T1
(de)
*
|
2000-08-28 |
2011-02-15 |
Oncomedx Inc |
5t4 rna in plasma und serum als marker für neoplastische erkrankungen
|
US6664056B2
(en)
|
2000-10-17 |
2003-12-16 |
The Chinese University Of Hong Kong |
Non-invasive prenatal monitoring
|
EP1379697A4
(de)
*
|
2001-03-30 |
2007-09-12 |
Chronix Biomedical Inc |
Diagnostischer nachweis von nukleinsäuren
|
AU2002345854A1
(en)
*
|
2001-06-25 |
2003-01-08 |
Oncomedx, Inc. |
Methods for detecting and monitoring cox-2 rna in plasma and serum
|
AU2002327308A1
(en)
*
|
2001-07-25 |
2003-02-17 |
Oncomedx Inc. |
Methods for evaluating pathologic conditions using extracellular rna
|
DE10143776A1
(de)
*
|
2001-09-06 |
2003-04-03 |
Adnagen Ag |
Verfahren und Kit zur Diagnostik oder Behandlungskontrolle von Brustkrebs
|
EP1409727B1
(de)
|
2001-09-06 |
2005-11-09 |
Adnagen AG |
Verfahren zum qualitativen und/oder quantitativen nachweis von zellen
|
DE10143775A1
(de)
*
|
2001-09-06 |
2003-04-10 |
Adnagen Ag |
Verfahren und Kit zur Diagnostik oder Behandlungskontrolle von Darmkrebs
|
US8980568B2
(en)
*
|
2001-10-11 |
2015-03-17 |
Aviva Biosciences Corporation |
Methods and compositions for detecting non-hematopoietic cells from a blood sample
|
US8986944B2
(en)
*
|
2001-10-11 |
2015-03-24 |
Aviva Biosciences Corporation |
Methods and compositions for separating rare cells from fluid samples
|
BR0213520A
(pt)
*
|
2001-10-26 |
2006-05-23 |
Immunivest Corp |
método para diagnosticar a gravidade de uma doença em um indivìduo de teste, e, kit de teste para triagem de uma amostra de paciente quanto à presença de células cancerosas circulantes
|
US20030104454A1
(en)
*
|
2001-11-05 |
2003-06-05 |
Kopreski Michael S. |
Method for detection of DNA methyltransferase RNA in plasma and serum
|
US20100159464A1
(en)
*
|
2001-11-05 |
2010-06-24 |
Oncomedx, Inc. |
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
|
CA2467629A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
WO2003048734A2
(en)
*
|
2001-12-03 |
2003-06-12 |
Oncomedx, Inc. |
Detection of matrix metalloproteinase rna in plasma and serum
|
EP2902501B1
(de)
*
|
2002-01-28 |
2020-04-15 |
Life Technologies Corporation |
Herstellung von biologischen, zur Herstellung von cDNS geeigneten Rohextrakten mittels Protease
|
US6977162B2
(en)
|
2002-03-01 |
2005-12-20 |
Ravgen, Inc. |
Rapid analysis of variations in a genome
|
US20050266405A1
(en)
*
|
2002-03-08 |
2005-12-01 |
Kopreski Michael S |
Analysis of apoptotic bodies in bodily fluids
|
US7727720B2
(en)
*
|
2002-05-08 |
2010-06-01 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
US7022478B2
(en)
*
|
2002-05-14 |
2006-04-04 |
The Chinese University Of Hong Kong |
Methods for evaluating stroke or cardiac ischemia by nucleic acid detection
|
US20040009518A1
(en)
*
|
2002-05-14 |
2004-01-15 |
The Chinese University Of Hong Kong |
Methods for evaluating a disease condition by nucleic acid detection and fractionation
|
US7252976B2
(en)
*
|
2002-08-28 |
2007-08-07 |
Board Of Regents The University Of Texas System |
Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample
|
AU2003254755B2
(en)
|
2002-10-16 |
2007-12-20 |
Streck, Inc. |
Method and device for collecting and preserving cells for analysis
|
US7074561B2
(en)
*
|
2002-10-22 |
2006-07-11 |
Biomerieux, Inc. |
Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
|
ES2311745T3
(es)
*
|
2002-12-31 |
2009-02-16 |
Pfizer Products Inc. |
Bioensayo de arn.
|
US20040137539A1
(en)
*
|
2003-01-10 |
2004-07-15 |
Bradford Sherry A. |
Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
|
US20040178208A1
(en)
*
|
2003-03-12 |
2004-09-16 |
Minh Leba |
Ice chest
|
CN100567985C
(zh)
*
|
2003-03-19 |
2009-12-09 |
财团法人浜松科学技术研究振兴会 |
大肠癌标记物的检测方法
|
TWI340168B
(en)
*
|
2003-05-07 |
2011-04-11 |
Tosoh Corp |
Method of detecting micrometastasis
|
WO2005014795A2
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
DE60309879D1
(de)
*
|
2003-10-29 |
2007-01-04 |
Maurice Stroun |
Verfahren zur Diagnose von Krebs
|
JP2008503206A
(ja)
*
|
2004-05-25 |
2008-02-07 |
日立化成工業株式会社 |
癌感受性を測定する方法
|
JP2008501336A
(ja)
*
|
2004-06-02 |
2008-01-24 |
ソースフアーム・インコーポレイテツド |
Rnaを含有する微小胞およびそのための方法
|
US8021847B2
(en)
|
2004-06-02 |
2011-09-20 |
Proxy Life Science Holdings, Inc. |
Microvesicle-based compositions and methods
|
US20060003345A1
(en)
|
2004-06-30 |
2006-01-05 |
Pfizer Inc |
RNA bioassay
|
WO2006042136A2
(en)
*
|
2004-10-07 |
2006-04-20 |
Chronix Biomedical |
Detection of nucleic acids to assess risk for creutzfeldt-jakob disease
|
US20090011410A1
(en)
*
|
2004-10-20 |
2009-01-08 |
Masato Mitsuhashi |
Method for tailoring administration of drugs by quantitation of mrna
|
US11105808B2
(en)
|
2004-11-12 |
2021-08-31 |
Health Discovery Corporation |
Methods for screening, predicting and monitoring prostate cancer
|
AU2005314089B2
(en)
*
|
2004-12-08 |
2011-03-03 |
Cedars-Sinai Medical Center |
Methods for diagnosis and treatment of Crohn's disease
|
WO2008109782A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
CA2599589A1
(en)
|
2005-02-07 |
2006-08-17 |
Genenews,Inc. |
Mild osteoarthritis biomarkers and uses thereof
|
ES2313143T3
(es)
|
2005-04-06 |
2009-03-01 |
Maurice Stroun |
Metodo para el diagnostico de cancer mediante la deteccion de adn y arn circulantes.
|
WO2006116721A1
(en)
*
|
2005-04-28 |
2006-11-02 |
Hitachi Chemical Research Center, Inc. |
Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements
|
US7741023B2
(en)
*
|
2005-06-08 |
2010-06-22 |
Hitachi Chemical Co., Ltd. |
Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
CN101233243A
(zh)
*
|
2005-08-10 |
2008-07-30 |
财团法人浜松科学技术研究振兴会 |
大肠癌标记的检测方法
|
US8249814B2
(en)
|
2005-10-21 |
2012-08-21 |
Genenews Inc. |
Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
|
WO2007117589A2
(en)
*
|
2006-04-07 |
2007-10-18 |
Hitachi Chemical Co., Ltd. |
Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
|
EP2005175B1
(de)
*
|
2006-04-07 |
2011-07-27 |
Hitachi Chemical Company, Ltd. |
ERHÖHTE EXPRESSION VON T-ZELLENREZEPTORVERMITTELTER TUMORNEKROSEFAKTORSUPERFAMILIE UND CHEMOKIN-MRNA IN PERIPHEREN BLUT LEUKOZYTEN BEI PATIENTEN MIT MORBUS& xA;CROHN
|
US20070248961A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Maher Albitar |
Methods for detecting mutations in JAK2 nucleic acid
|
US20090298071A1
(en)
*
|
2006-05-08 |
2009-12-03 |
Masato Mitsuhashi |
Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue
|
US7798645B2
(en)
*
|
2006-05-16 |
2010-09-21 |
Mark Costin Roser |
Visual and memory stimulating retina self-monitoring system
|
EP2041299A4
(de)
|
2006-07-14 |
2010-01-13 |
Aviva Biosciences Corp |
Verfahren und zusammensetzungen für den nachweis seltener zellen aus einer biologischen probe
|
US20100021917A1
(en)
*
|
2007-02-14 |
2010-01-28 |
Cedars-Sinai Medical Center |
Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
|
US20100190162A1
(en)
*
|
2007-02-26 |
2010-07-29 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
|
WO2010039931A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Cedars-Sinai Medical Center |
Methods of using il17rd and il23-il17 pathway genes to diagnose crohn's disease
|
WO2008116150A2
(en)
|
2007-03-21 |
2008-09-25 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
|
US8652780B2
(en)
|
2007-03-26 |
2014-02-18 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
AU2008239594B2
(en)
|
2007-04-13 |
2013-10-24 |
Beth Israel Deaconess Medical Center |
Methods for treating cancer resistant to ErbB therapeutics
|
WO2008134569A2
(en)
*
|
2007-04-26 |
2008-11-06 |
Cedars-Sinai Medical Center |
Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
|
US20100144903A1
(en)
*
|
2007-05-04 |
2010-06-10 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
US7964350B1
(en)
|
2007-05-18 |
2011-06-21 |
Applied Biosystems, Llc |
Sample preparation for in situ nucleic acid analysis
|
US20090136942A1
(en)
*
|
2007-09-18 |
2009-05-28 |
Oncomedx, Inc. |
Analysis of Extracellular RNA
|
US20090123920A1
(en)
*
|
2007-11-08 |
2009-05-14 |
Maher Albitar |
Jak2 mutations
|
CN101855367A
(zh)
*
|
2007-11-14 |
2010-10-06 |
日立化成工业株式会社 |
外周血白细胞中FC受体介导的肿瘤坏死因子超家族mRNA表达
|
ES2936256T3
(es)
*
|
2008-02-01 |
2023-03-15 |
Massachusetts Gen Hospital |
Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
|
US20090215064A1
(en)
*
|
2008-02-27 |
2009-08-27 |
Hitachi Chemical Co., Ltd. |
Quantitative assessment of individual cancer susceptibility by measuring dna damage-induced mrna in whole blood
|
AU2009223671B2
(en)
*
|
2008-03-11 |
2014-11-27 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
CA2718137A1
(en)
|
2008-03-26 |
2009-10-01 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US8614057B2
(en)
*
|
2008-06-12 |
2013-12-24 |
The Invention Science Fund I, Llc |
Methods for collecting and detecting oligonucleotides
|
US8252529B2
(en)
*
|
2008-06-12 |
2012-08-28 |
The Invention Science Fund I, Llc |
Methods for collecting and detecting oligonucleotides
|
US8252528B2
(en)
*
|
2008-06-12 |
2012-08-28 |
The Invention Science Fund I, Llc |
Methods, compositions, and kits for collecting and detecting oligonucleotides
|
CN102105598A
(zh)
*
|
2008-06-20 |
2011-06-22 |
代理生命科学控股公司 |
基于微泡的组合物和方法
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US20110189685A1
(en)
*
|
2008-10-22 |
2011-08-04 |
Cedars-Sinai Medical Center |
Methods of using jak3 genetic variants to diagnose and predict crohn's disease
|
CA2742324A1
(en)
|
2008-10-30 |
2010-06-03 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Methods for assessing rna patterns
|
US9702877B2
(en)
*
|
2008-10-31 |
2017-07-11 |
Quest Diagnostics Investments Incorporated |
BCR-ABL variants
|
CA2743211A1
(en)
|
2008-11-12 |
2010-05-20 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Methods and systems of using exosomes for determining phenotypes
|
US20110229471A1
(en)
*
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
EP2955233A1
(de)
*
|
2008-12-19 |
2015-12-16 |
Life Technologies Corporation |
Proteinase K Inhibitore, Verfahren und Zusammensetzungen davon
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
US20100167271A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
WO2010079118A1
(en)
|
2009-01-07 |
2010-07-15 |
Michael Roth-Chiarello |
Use of rna obtained from proteolipid complexes circulating in blood for diagnosis and treatment of tumors
|
US11634747B2
(en)
*
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
EP3290530B1
(de)
|
2009-02-18 |
2020-09-02 |
Streck Inc. |
Konservierung von zellfreien nukleinsäuren
|
US20110105585A1
(en)
*
|
2009-04-23 |
2011-05-05 |
Northwestern University |
METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
|
WO2010135692A2
(en)
|
2009-05-22 |
2010-11-25 |
Asuragen, Inc. |
Mirna biomarkers of prostate disease
|
BR112012001077A2
(pt)
*
|
2009-07-16 |
2020-08-11 |
The General Hospital Corporation |
extração de ácido nucleico, métodos para avaliar a qualidade de uma extração de ácido nucleico e de uma amostra biológica, para ober ácido nucleico a partir de uma amostra biológica, para analisar rna de microvesículas e para diagnosticar e monitorar um indivíduo, e, kit
|
WO2011025919A1
(en)
|
2009-08-28 |
2011-03-03 |
Asuragen, Inc. |
Mirna biomarkers of lung disease
|
EP2475989A4
(de)
|
2009-09-09 |
2013-02-27 |
Gen Hospital Corp |
Verwendung von mikrovesikeln bei der analyse von kras-mutationen
|
EP3461912B1
(de)
|
2009-09-09 |
2022-07-13 |
The General Hospital Corporation |
Verwendung von mikrovesikeln bei der analyse von nukleinsäureprofilen
|
US9488656B2
(en)
*
|
2009-09-30 |
2016-11-08 |
Quest Diagnostics Investments Incorporated |
BCR-ABL truncation mutations
|
EP3103883A1
(de)
*
|
2009-11-09 |
2016-12-14 |
Streck, Inc. |
Stabilisierung von rna in und extraktion aus intakten zellen in einer blutprobe
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
US9128101B2
(en)
|
2010-03-01 |
2015-09-08 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarkers for theranostics
|
JP2013526852A
(ja)
|
2010-04-06 |
2013-06-27 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
疾患に対する循環バイオマーカー
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
CA2798758C
(en)
|
2010-05-18 |
2019-05-07 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
BR112012031045A2
(pt)
*
|
2010-06-07 |
2017-06-20 |
Ashur Fabian Osnat |
métodos para detecção de uma condição, para determinar a eficácia de um tratmento terapêutico de uma condição, e para a seleção de um sujeito que sofre de uma condição, e, kit.
|
WO2011156763A1
(en)
|
2010-06-11 |
2011-12-15 |
Hitachi Chemical Co., Ltd. |
Methods for characterizing kidney function
|
WO2011156734A2
(en)
*
|
2010-06-11 |
2011-12-15 |
Hitachi Chemical Co., Ltd. |
Method of characterizing vascular diseases
|
US11203786B2
(en)
*
|
2010-08-06 |
2021-12-21 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
US20130261003A1
(en)
|
2010-08-06 |
2013-10-03 |
Ariosa Diagnostics, In. |
Ligation-based detection of genetic variants
|
US20140342940A1
(en)
|
2011-01-25 |
2014-11-20 |
Ariosa Diagnostics, Inc. |
Detection of Target Nucleic Acids using Hybridization
|
US20120034603A1
(en)
|
2010-08-06 |
2012-02-09 |
Tandem Diagnostics, Inc. |
Ligation-based detection of genetic variants
|
US10167508B2
(en)
|
2010-08-06 |
2019-01-01 |
Ariosa Diagnostics, Inc. |
Detection of genetic abnormalities
|
US11031095B2
(en)
|
2010-08-06 |
2021-06-08 |
Ariosa Diagnostics, Inc. |
Assay systems for determination of fetal copy number variation
|
US10533223B2
(en)
|
2010-08-06 |
2020-01-14 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
US8700338B2
(en)
|
2011-01-25 |
2014-04-15 |
Ariosa Diagnosis, Inc. |
Risk calculation for evaluation of fetal aneuploidy
|
US20130040375A1
(en)
|
2011-08-08 |
2013-02-14 |
Tandem Diagnotics, Inc. |
Assay systems for genetic analysis
|
WO2012031008A2
(en)
|
2010-08-31 |
2012-03-08 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
CA2817111C
(en)
|
2010-11-10 |
2019-03-05 |
Exosome Diagnostics, Inc. |
Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
|
US8603740B2
(en)
|
2010-12-29 |
2013-12-10 |
Quest Diagnostics Investments Incorporated |
BCR-ABL1 splice variants and uses thereof
|
US9994897B2
(en)
|
2013-03-08 |
2018-06-12 |
Ariosa Diagnostics, Inc. |
Non-invasive fetal sex determination
|
US11270781B2
(en)
|
2011-01-25 |
2022-03-08 |
Ariosa Diagnostics, Inc. |
Statistical analysis for non-invasive sex chromosome aneuploidy determination
|
US8756020B2
(en)
|
2011-01-25 |
2014-06-17 |
Ariosa Diagnostics, Inc. |
Enhanced risk probabilities using biomolecule estimations
|
US10131947B2
(en)
|
2011-01-25 |
2018-11-20 |
Ariosa Diagnostics, Inc. |
Noninvasive detection of fetal aneuploidy in egg donor pregnancies
|
GB201105295D0
(en)
*
|
2011-03-29 |
2011-05-11 |
Univ Liverpool |
Cancer detection
|
AU2012249531B2
(en)
|
2011-04-29 |
2017-06-29 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
US9956281B2
(en)
|
2011-05-04 |
2018-05-01 |
Streck, Inc. |
Inactivated virus compositions and methods of preparing such compositions
|
US9719129B2
(en)
|
2011-06-10 |
2017-08-01 |
Hitachi Chemical Co., Ltd. |
Methods for isolating vesicles from biological fluids
|
GB201115095D0
(en)
*
|
2011-09-01 |
2011-10-19 |
Singapore Volition Pte Ltd |
Method for detecting nucleosomes containing nucleotides
|
US8712697B2
(en)
|
2011-09-07 |
2014-04-29 |
Ariosa Diagnostics, Inc. |
Determination of copy number variations using binomial probability calculations
|
US11021733B2
(en)
|
2011-09-26 |
2021-06-01 |
Qiagen Gmbh |
Stabilization and isolation of extracellular nucleic acids
|
ES2687126T3
(es)
|
2011-09-26 |
2018-10-23 |
Qiagen Gmbh |
Estabilización y aislamiento de ácidos nucleicos extracelulares
|
JP6155269B2
(ja)
|
2011-09-26 |
2017-06-28 |
プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
細胞外核酸の安定化および単離
|
CN103930546A
(zh)
|
2011-09-26 |
2014-07-16 |
凯杰有限公司 |
用于分离细胞外核酸的快速方法
|
WO2013064163A1
(en)
|
2011-11-01 |
2013-05-10 |
Academisch Medisch Centrum |
Methylation markers for colorectal cancer
|
JP2015503356A
(ja)
|
2012-01-06 |
2015-02-02 |
バイオミクス, インコーポレイテッドViomics, Inc. |
末梢血中で、がんによって変化したrnaを検出するシステムおよび方法
|
EP4361609A2
(de)
|
2012-02-03 |
2024-05-01 |
California Institute of Technology |
Signalkodierung und -dekodierung in multiplexierten biochemischen assays
|
EP2820129A1
(de)
|
2012-03-02 |
2015-01-07 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US10289800B2
(en)
|
2012-05-21 |
2019-05-14 |
Ariosa Diagnostics, Inc. |
Processes for calculating phased fetal genomic sequences
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
BR112014032728A2
(pt)
|
2012-06-27 |
2017-11-28 |
Berg Llc |
uso de marcadores no diagnóstico e tratamento de câncer de próstata
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2875156A4
(de)
|
2012-07-19 |
2016-02-24 |
Ariosa Diagnostics Inc |
Sequentielle ligationsbasierte multiplex-detektion von genetischen varianten
|
CN104662172B
(zh)
|
2012-08-03 |
2018-07-06 |
加州理工学院 |
Pcr中具有减少的硬件和要求的多重化和定量
|
US10876152B2
(en)
|
2012-09-04 |
2020-12-29 |
Guardant Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
US20160040229A1
(en)
|
2013-08-16 |
2016-02-11 |
Guardant Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
US11913065B2
(en)
|
2012-09-04 |
2024-02-27 |
Guardent Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
PT2893040T
(pt)
|
2012-09-04 |
2019-04-01 |
Guardant Health Inc |
Métodos para deteção de mutações raras e de variação do número de cópias
|
AU2013322643C1
(en)
|
2012-09-25 |
2018-11-08 |
Qiagen Gmbh |
Stabilisation of biological samples
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
US10450595B2
(en)
|
2013-03-15 |
2019-10-22 |
Theranos Ip Company, Llc |
Nucleic acid amplification
|
WO2014145291A1
(en)
|
2013-03-15 |
2014-09-18 |
Theranos, Inc. |
Nucleic acid amplification
|
ES2908751T3
(es)
|
2013-03-15 |
2022-05-03 |
Labrador Diagnostics Llc |
Amplificación de ácidos nucleicos
|
WO2014145296A2
(en)
|
2013-03-15 |
2014-09-18 |
Theranos, Inc. |
Nuclei acid amplification
|
JP6381628B2
(ja)
|
2013-03-18 |
2018-08-29 |
キアゲン ゲーエムベーハー |
生物試料の安定化
|
EP2976426A1
(de)
|
2013-03-18 |
2016-01-27 |
Qiagen GmbH |
Stabilisierung und isolierung extrazellulärer nukleinsäuren
|
AU2014241162A1
(en)
|
2013-03-27 |
2015-10-22 |
Cedars-Sinai Medical Center |
Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
|
DE212013000295U1
(de)
|
2013-05-06 |
2016-02-02 |
Hitachi Chemical Co. America, Ltd. |
Vorrichtungen zum Einfangen von Zielmolekülen
|
EP4105236A1
(de)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anti-tl1a (tnfsf15) antikörper zur behandlung von entzündlichen darmerkrankungen
|
WO2015013244A1
(en)
|
2013-07-24 |
2015-01-29 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
US9644232B2
(en)
|
2013-07-26 |
2017-05-09 |
General Electric Company |
Method and device for collection and amplification of circulating nucleic acids
|
CA2920896A1
(en)
|
2013-09-06 |
2015-03-12 |
Theranos, Inc. |
Systems and methods for detecting infectious diseases
|
FR3010530B1
(fr)
*
|
2013-09-11 |
2015-10-09 |
Univ Rouen |
Methode de diagnostic des hemopathies malignes et kit associe
|
EP3049539B1
(de)
|
2013-09-25 |
2018-09-05 |
Bio-Id Diagnostic Inc. |
Verfahren für den nachweis von nukleinsäurefragmenten
|
EP3080298B1
(de)
|
2013-12-11 |
2018-10-31 |
AccuraGen Holdings Limited |
Verfahren für den nachweis seltener sequenzvarianten
|
US11859246B2
(en)
|
2013-12-11 |
2024-01-02 |
Accuragen Holdings Limited |
Methods and compositions for enrichment of amplification products
|
US11286519B2
(en)
|
2013-12-11 |
2022-03-29 |
Accuragen Holdings Limited |
Methods and compositions for enrichment of amplification products
|
AU2014369841B2
(en)
|
2013-12-28 |
2019-01-24 |
Guardant Health, Inc. |
Methods and systems for detecting genetic variants
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
WO2015140218A1
(en)
|
2014-03-18 |
2015-09-24 |
Qiagen Gmbh |
Stabilization and isolation of extracellular nucleic acids
|
AU2015249846B2
(en)
|
2014-04-21 |
2021-07-22 |
Natera, Inc. |
Detecting mutations and ploidy in chromosomal segments
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗mfi2抗體及使用方法
|
US10266895B2
(en)
|
2014-11-05 |
2019-04-23 |
Hitachi Chemical Company Ltd. |
Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
|
US10370719B2
(en)
|
2014-11-12 |
2019-08-06 |
Hitachi Chemical Co., Ltd. |
Method and device for diagnosing organ injury
|
WO2016077709A1
(en)
|
2014-11-14 |
2016-05-19 |
Liquid Genomics, Inc. |
Use of circulating cell-free rna for diagnosis and/or monitoring cancer
|
SG10202012249YA
(en)
|
2014-12-08 |
2021-01-28 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
WO2016094330A2
(en)
|
2014-12-08 |
2016-06-16 |
20/20 Genesystems, Inc |
Methods and machine learning systems for predicting the liklihood or risk of having cancer
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
PL3277272T3
(pl)
|
2015-03-31 |
2022-01-24 |
Syros Pharmaceuticals, Inc. |
Sposoby stratyfikacji pacjentów do leczenia agonistami receptora kwasu retinowego
|
WO2016183106A1
(en)
|
2015-05-11 |
2016-11-17 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
AU2016277476B2
(en)
|
2015-06-10 |
2022-07-21 |
Qiagen Gmbh |
Method for isolating extracellular nucleic acids using anion exchange particles
|
US11028443B2
(en)
|
2015-08-31 |
2021-06-08 |
Showa Denko Materials Co., Ltd. |
Molecular methods for assessing urothelial disease
|
EP3359693A4
(de)
|
2015-10-09 |
2019-03-06 |
Accuragen Holdings Limited |
Verfahren und zusammensetzungen zur anreicherung von amplifikationsprodukten
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
CN108291250B
(zh)
|
2015-11-20 |
2022-05-27 |
凯杰有限公司 |
用于稳定细胞外核酸的已灭菌组合物的制备方法
|
EP3390668A4
(de)
|
2015-12-17 |
2020-04-01 |
Guardant Health, Inc. |
Verfahren zur bestimmung der tumorgenkopienzahl durch analyse von zellfreier dna
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
US9868994B2
(en)
|
2016-04-08 |
2018-01-16 |
Syros Pharmaceuticals, Inc. |
Methods of stratifying patients for treatment with retinoic acid receptor-α agonists
|
CA3024630A1
(en)
|
2016-05-16 |
2017-11-23 |
Accuragen Holdings Limited |
Method of improved sequencing by strand identification
|
EP3472354A4
(de)
|
2016-06-17 |
2020-01-01 |
California Institute of Technology |
Nukleinsäurereaktionen sowie zugehörige verfahren und zusammensetzungen
|
US11506655B2
(en)
|
2016-07-29 |
2022-11-22 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
WO2018035170A1
(en)
|
2016-08-15 |
2018-02-22 |
Accuragen Holdings Limited |
Compositions and methods for detecting rare sequence variants
|
CA3027919C
(en)
|
2016-09-30 |
2023-02-28 |
Guardant Health, Inc. |
Methods for multi-resolution analysis of cell-free nucleic acids
|
US9850523B1
(en)
|
2016-09-30 |
2017-12-26 |
Guardant Health, Inc. |
Methods for multi-resolution analysis of cell-free nucleic acids
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
WO2018146162A1
(en)
|
2017-02-07 |
2018-08-16 |
Academisch Medisch Centrum |
Molecular biomarker for prognosis of sepsis patients
|
US10907211B1
(en)
|
2017-02-16 |
2021-02-02 |
Quantgene Inc. |
Methods and compositions for detecting cancer biomarkers in bodily fluids
|
WO2019045803A1
(en)
*
|
2017-09-01 |
2019-03-07 |
Genemo Inc. |
RNA SEQUENCING METHODS
|
US11203782B2
(en)
|
2018-03-29 |
2021-12-21 |
Accuragen Holdings Limited |
Compositions and methods comprising asymmetric barcoding
|
CN108949906B
(zh)
*
|
2018-06-22 |
2020-12-18 |
中南大学 |
一种用于HER2检测的dsDNA-AgNCs荧光探针及其构建方法和应用
|
US11525159B2
(en)
|
2018-07-03 |
2022-12-13 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
AU2020216438A1
(en)
|
2019-01-31 |
2021-07-29 |
Guardant Health, Inc. |
Compositions and methods for isolating cell-free DNA
|
US20220259637A1
(en)
|
2019-06-28 |
2022-08-18 |
Qiagen Gmbh |
Method for enriching nucleic acids by size
|